Yoshinobu Yasuda

Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats

Takeshi Tani, Kenji Uehara, Toshiki Sudo et al. · Atherosclerosis · 2000 · 75 citations

Metabolic Syndrome, Lipoprotein Lipase Activity, Lipid Synthesis +10

Effects of cilostazol on the peripheral nerve function and structure in STZ-induced diabetic rats

Kenji Uehara, K Sugimoto, Ryuichi Wada et al. · Journal of Diabetes and its Complications · 1997 · 33 citations

Peripheral Nerve Function, Medicine, Diabetes +7

Effects of cilostazol, an antiplatelet agent, on axonal regeneration following nerve injury in diabetic rats

Yasuchika Yamamoto, Yoshinobu Yasuda, Yukio Kimura et al. · European Journal of Pharmacology · 1998 · 25 citations

Neuroregeneration, Peripheral Nerve Injury, Medicine +10

The Metabolism of a Bronchodilator Procaterol HCl in the Rat<i>in vitro</i>and<i>in vivo</i>

Takae Shimizu, Hirotoshi Mori, E. Tabusa et al. · Xenobiotica · 1978 · 11 citations

Gastrointestinal Pharmacology, Procaterol Hcl, Experimental Pharmacology +19